Bryan Abney brings more than 30 years of pharmaceutical quality experience spanning quality control, analytical development, validation, and quality assurance. He has led successful remediation efforts that improved laboratory capabilities, compliance, and efficiency, with a proven record in project management, cost reduction, and stakeholder collaboration.

His expertise includes Quality Management Systems, analytical chemistry, and regulatory compliance with FDA and ICH guidelines. Bryan previously held leadership roles at Polypeptide Group, Catalent Pharma Solutions, Sovereign Pharmaceuticals, Jim Beam Brands, Eli Lilly, Kimberly-Clark, and Mallinckrodt Medical. He holds degrees from Eastern Kentucky University and the University of Saint Louis, Missouri.